Hepcidin expression from monocyte of splenectomized and non-splenectomized patients with HbE-β-thalassemia

References

• Ganz T. Hepcidin-a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol. 2005;18:171–82.
   PubMed Web of Science ®Google Scholar
• Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000;480:147–50.
   PubMed Web of Science ®Google Scholar
• Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276:7806–10.
   PubMed Web of Science ®Google Scholar
• Kulaksiz H, Theilig F, Bachmann S, Gehrke SG, Rost D, Janetzko A, et al. The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol. 2005;184:361–70.
   PubMed Web of Science ®Google Scholar
• Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006;131:788–96.
   PubMed Web of Science ®Google Scholar
• Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, Lafuse WP. Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. J Leukoc Biol. 2007;82:934–45.
   PubMed Web of Science ®Google Scholar
• Theurl I, Theurl M, Seifert M, Mair S, Nairz M, Rumpold H, et al. Autocrine formation of hepcidin induces iron retention in human monocytes. Blood 2008;111:2392–9.
   PubMed Web of Science ®Google Scholar
• Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090–3.
   PubMed Web of Science ®Google Scholar
• Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr. 2006;26:323–42.
   PubMed Web of Science ®Google Scholar
• Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003;101:2461–3.
   PubMed Web of Science ®Google Scholar
• Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110:1037–44.
   PubMed Web of Science ®Google Scholar
• Weatherall DJ, Clegg JB. The thalassemia syndromes. 4th ed. Oxford: Blackwell; 2001.
   Google Scholar
• Walker EM Jr., Walker SM. Effects of iron overload on the immune system. Ann Clin Lab Sci. 2000;30:354–65.
   PubMed Web of Science ®Google Scholar
• Wanachiwanawin W. Infections in E-beta thalassemia. J Pediatr Hematol Oncol. 2000;22:581–7.
   PubMed Web of Science ®Google Scholar
• Aswapokee N, Aswapokee P, Fucharoen S, Wasi P. A study of infective episodes in patients with beta-thalassemia/Hb E disease in Thailand. Birth Defects Orig Artic Ser. 1987;23:513–20.
   PubMedGoogle Scholar
• Archararit N, Chuncharunee S, Pornvoranunt A, Atamasirikul K, Rachakom B, Atichartakarn V. Serum C-reactive protein level in postsplenectomized thalassemic patients. J Med Assoc Thai. 2000;83 (Suppl. 1):S63–9.
   PubMedGoogle Scholar
• Chuncharunee S, Archararit N, Hathirat P, Udomsubpayakul U, Atichartakarn V. Levels of serum interleukin-6 and tumor necrosis factor in postsplenectomized thalassemic patients. J Med Assoc Thai. 1997;80 (Suppl. 1):S86–91.
   PubMedGoogle Scholar
• Jetsrisuparb A, Jetsrisuparb C. Infections and illnesses in children with Hb E beta-thalassemia: a prospective controlled study. J Med Assoc Thai. 2010;93:48–55.
   PubMedGoogle Scholar
• Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, et al. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica. 2007;92(5):583–8.
   PubMed Web of Science ®Google Scholar
• Kattamis A, Papassotiriou I, Palaiologou D, Apostolakou F, Galani A, Ladis V, et al. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major. Haematologica. 2006;91(6):809–12.
   PubMed Web of Science ®Google Scholar
• Fucharoen G, Sanchaisuriya K, Sae-ung N, Dangwibul S, Fucharoen S. A simplified screening strategy for thalassaemia and haemoglobin E in rural communities in south-east Asia. Bull World Health Organ. 2004;82(5):364–72.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 2001;25:402–8.
   PubMed Web of Science ®Google Scholar
• Bain BJ, Bates I, Laffan MA, Lewis SM. Dacie and Lewis practical haematology. 11th ed. China: Churchill Livingstone; 2012.
   Google Scholar
• Cappellini M-D, Cohen A, Eleftheriou A, Piga A, Porter J, Taher A. Guidelines for the clinical management of thalassaemia. 2nd ed. Nicosia, Cyprus: TIF; 2007.
   Google Scholar
• Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276(11):7811–9.
   PubMed Web of Science ®Google Scholar
• Huebers HA, Beguin Y, Pootrakul P, Einspahr D, Finch CA. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood 1990;75(1):102–7.
   PubMed Web of Science ®Google Scholar
• Suominen P, Virtanen A, Lehtonen-Veromaa M, Heinonen OJ, Salmi TT, Alanen M, et al. Regression-based reference limits for serum transferrin receptor in children 6 months to 16 years of age. Clin Chem. 2001;47(5):935–7.
   PubMed Web of Science ®Google Scholar
• Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990;265:621–36.
   PubMed Web of Science ®Google Scholar
• Clyne B, Olshaker JS. The C-reactive protein. J Emerg Med. 1999;17(6):1019–25.
   PubMed Web of Science ®Google Scholar
• Aggeli C, Antoniades C, Cosma C, Chrysohoou C, Tousoulis D, Ladis V, et al. Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major. Int J Cardiol. 2005;105(1):80–4.
   PubMed Web of Science ®Google Scholar
• Angchaisuksiri P, Atichartakarn V, Aryurachai K, Archararit N, Chuncharunee S, Tiraganjana A, et al. Hemostatic and thrombotic markers in patients with hemoglobin E/beta-thalassemia disease. Am J Hematol. 2007;82(11):1001–4.
   PubMed Web of Science ®Google Scholar
• Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271–6.
   PubMed Web of Science ®Google Scholar